Versant Venture Capital VI, L.P. - Sep 16, 2025 SCHEDULE 13D/A Report for LAVA Therapeutics N.V. Common Shares, par value Euro 0.12 per share (LVTX)

Filing Manager
Versant Venture Capital VI, L.P.
Reporting Manager
Versant Venture Capital VI, L.P.
Security
LAVA Therapeutics N.V. Common Shares, par value Euro 0.12 per share
Symbol
LVTX
Shares outstanding
26.3M shares
Disclosed Ownership
2.37M shares
Ownership
9%
Form type
SCHEDULE 13D/A
Date filed
9/18/2025, 07:08 PM
Date of event
Sep 16, 2025
Next filing
Sep 23, 2025
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Versant Venture Capital VI, L.P. 9% 2.37M 2.37M 0 /s/Max Eisenberg Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the GP of Versant Ventures VI GP, L.P., the GP of Versant Venture Capital VI, L.P. 0001687880
Versant Ventures VI GP, L.P. 9% 2.37M 0 2.37M /s/Max Eisenberg Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the GP of Versant Ventures VI GP, L.P., the GP of Versant Venture Capital VI, L.P. 0001777654
Versant Ventures VI GP-GP, LLC 9% 2.37M 0 2.37M /s/Max Eisenberg Max Eisenberg/COO of Versant Ventures VI GP-GP, LLC, the GP of Versant Ventures VI GP, L.P., the GP of Versant Venture Capital VI, L.P. 0001777652
Versant Vantage I, L.P. 2% 533K 533K 0 /s/Max Eisenberg Max Eisenberg/COO of Versant Vantage I GP-GP, LLC, the GP of Versant Vantage I GP, L.P., the GP of Versant Vantage I, L.P. 0001765253
Versant Vantage I GP, L.P. 2% 533K 0 533K /s/Max Eisenberg Max Eisenberg/COO of Versant Vantage I GP-GP, LLC, the GP of Versant Vantage I GP, L.P., the GP of Versant Vantage I, L.P. 0001777651
Versant Vantage I GP-GP, LLC 2% 533K 0 533K /s/Max Eisenberg Max Eisenberg/COO of Versant Vantage I GP-GP, LLC, the GP of Versant Vantage I GP, L.P., the GP of Versant Vantage I, L.P. 0001777653